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Abstract
Background: Although extensive research has been performed to control differentiation of
neural stem cells – still, the response of those cells to diverse cell culture conditions often appears
to be random and difficult to predict. To this end, we strived to obtain stabilized protocol of NHA
cells differentiation – allowing for an increase in percentage yield of neuronal cells.
Results: Uncommitted GFAP and SOX2 positive neural progenitors – so-called, Normal Human
Astrocytes (NHA) were differentiated in different environmental conditions to: only neural cells
consisted of neuronal [MAP2+, GFAP-] and glial [GFAP+, MAP2-] population, non-neural cells
[CD44+, VIMENTIN+, FIBRONECTIN+, MAP2-, GFAP-, S100β-, SOX2-], or mixture of neural
and non-neural cells.
In spite of successfully increasing the percentage yield of glial and neuronal vs. non-neural cells by
means of environmental changes, we were not able to increase significantly the percentage of
neuronal (GABA-ergic and catecholaminergic) over glial cells under several different cell culture
testing conditions. Supplementing serum-free medium with several growth factors (SHH, bFGF,
GDNF) did not radically change the ratio between neuronal and glial cells – i.e., 1,1:1 in medium
without growth factors and 1,4:1 in medium with GDNF, respectively.
Conclusion: We suggest that biotechnologists attempting to enrich in vitro neural cell cultures in
one type of cells – such as that required for transplantology purposes, should consider the strong
limiting influence of intrinsic factors upon extracellular factors commonly tested in cell culture
conditions.
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So-called NHA (Normal Human Astrocytes) cells belong
to the class of GFAP-positive neural progenitors. Expres-
sion of neuronal and glial markers during differentiation
of these cells is regulated in accordance with the "model
of discordant phenotypes suppression" [1-3]. This model
states that before differentiation, markers belonging to
diverse lineages are expressed by stem cells or progenitors;
whereas during differentiation, genes superfluous in
derived lines are silenced. In accordance with this concept,
uncommitted neural progenitors (NHA) co-express glial
[GFAP, CD44], neuronal [β-III-TUBULIN, MAP2] and
progenitor [NESTIN] markers. GFAP positive neural pro-
genitors (NHA) derivatives differentiating to the neuronal
lineage demonstrated silencing of glial and progenitor
markers [GFAP, CD44, NESTIN] expression, while those
differentiating to the glial lineage showed silencing of
neuronal and progenitor markers [β-III-TUBULIN, MAP2,
NESTIN] expression. However expression of MAP2 and β-
III-TUBULIN is definitely increased in neuronal deriva-
tives of NHA [1,2].
We could not prove so far that the coexpression of glial
and neuronal markers is a consequence of physiological
process. To this end we consider our investigation as bio-
technologically useful, and we do not imply that a similar
scenario has to occur in vivo. However report revealing
presence of neural stem cells or progenitors expressing
neuronal markers in vivo has been published lately by
Walker et al [4]. Coexpression of glial and neuronal mark-
ers in neural progenitors was also presented [5]. Moreo-
ver, article showing human fetal astrocytes coexpressing in
vivo GFAP, β-III-TUBULIN and MAP2 was published [6].
The expression of β-III-TUBULIN in conjunction with
MAP2 in GFAP-positive radial glia has been considered as
suggestion of neuronal-glial bipotentiality [7]. Radial glia
are recognized as cells presenting NSCs properties [7,8].
According to the suppression of discordant phenotypes
model, the expression of markers characteristic for partic-
ular lineages in progenitor cells allows for the presump-
tion of potential derivatives that can be obtained after
differentiation. This model, however, is of very limited
help in the biotechnological regulation of differentiation.
Hence, we took into account others such as the instruc-
tive, stochastic, and continuum models – considering the
possibility that they can help to increase the percentage
yield of a given required cell type via cell culture manipu-
lations.
The instructive (deterministic) model recognizes growth
factors as elements which determine the fate of stem cells
– thereby, triggering a particular differentiation pathway
[9,10]. Extensive research has shown that the fate of stem
cells can be influenced by exogenous factors. However,
their response to environmental signals often emerge to
be random and difficult to predict. To this end, biologists
have realised that an alternative model to the determinis-
tic one would be required to explain better how the differ-
entiation process is regulated. Hence, difficulties in
predicting the response of stem cells have inspired a con-
sideration of the stochastic models [11].
A stochastic model was popularized amongst haematolo-
gists by papers such as the one by Enver titled "Do stem
cells play dice?" [12]. According to this view, it is stochastic
events that trigger diverse intracellular programs to regu-
late the differentiation of cells. The stochastic model rec-
ognizes growth factors as the important but permissive
regulators of differentiation that support the survival and
proliferation of one or a few already determined cell
type(s) [13]. Neurobiologists had started acknowledging a
long time ago that stochastic events might play an impor-
tant role during differentiation [14]. In time, however,
deterministic models became more popular amongst
them [15-17].
Another popular model of differentiation is the contin-
uum model. This model refers to the phenotypical
changes that occur in stem cells during the cell cycle [18].
The continuum model is based on the assumption that
periodical and fluctuating phenotypical changes in stem
cells cause the inevitable heterogeneity of their popula-
tion, which – in turn, is responsible for the difference in
their response to the environment.
However, recognizing the very different nature of events
that determines the fate of progenitors or stem cells, both
– stochastic and continuum, models have identified intra-
cellular events as having the limiting influence on extra-
cellular factors.
The literature data showing that developmental options of
very restricted precursors (lymphoblasts, glial restricted
precursors), can be analysed as inclined (predisposed) by
both extracellular and intracellular events [19,20],
empowered us to transfer similar experimental attempt to
investigate differentiation of neural progenitor cells
(NHA).
We report here that the simultaneous consideration of
more than one differentiation model may help in (a) con-
trolling (understanding) human neural progenitor cells
(NHA) differentiation, and (b) recognizing the limita-
tions of typical biotechnological manipulations of cell
cultures.Page 2 of 12
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Expansion of GFAP-positive neural progenitors (NHA)
NHA isolated from the cerebrum of human foetuses were
purchased from Cambrex (CC-2565, NHA-Normal
Human Astrocytes; Walkersville, MD). NHA cells were
cultured by plating at a density of 10 000–15 000 cells/
cm2 in expansion medium (Cambrex AGM Bullet Kit: 3%
FBS – fetal bovine serum, rhEGF – recombinant human
epidermal growth factor, insulin and ascorbic acid), in
accordance with the manufacturer's protocol. The cells
were incubated at 37°C with 5% humidified CO2 and
allowed to reach confluence during 1–2 days. Once they
have reached about 95% or 50% of confluence, the cells
were then either used for differentiation purposes or were
harvested with 0.25% trypsin and 1 mM EDTA for 5 min
at 37°C counted, and passaged.
Protocols of differentiation
1. Differentiation of GFAP+ neural progenitors to non-neural cells
GFAP-positive neural progenitors (NHA) were plated on
six well dishes or uncoated chambers (Nunc) at a density
of 10 000–15 000 cells/cm2 and passaged in expansion
medium containing 3% FBS, rhEGF, insulin and ascorbic
acid (Cambrex AGM Bullet Kit). After every passage, the
cells were cultured for 5 days before the next passage was
performed.
2. Differentiation of GFAP+ neural progenitors to neuronal and glial 
populations
GFAP-positive neural progenitors (NHA) at the passage 0
were plated at a density of 10 000–15 000 cells/cm2 on
Matrigel thin-coated (according manufacturer's protocol,
BD Biosciences), chamber slides and cultured in expan-
sion medium (Cambrex AGM Bullet Kit) until reaching
confluence. After reaching confluence, the medium was
changed to N2- or B27-supplemented DMEM F12 (Invit-
rogen). A final concentration of 10 ng/ml of growth factor
was achieved with the optional addition of either bFGF –
basic fibroblast growth factor, SHH – sonic hedgehog or
GDNF – glial derived neutrophic factor (Invitrogen). The
cells were then cultured under differentiation conditions
for 5–7 days, with medium replacement every 2 days.
3. Differentiation of GFAP+ progenitors to neuronal, glial and non-
neural cells
GFAP+ neural progenitors were plated on six well dishes
or uncoated chambers at a density of 10 000–15 000 cells/
cm2 and kept for one to two passages in expansion
medium (Cambrex AGM Bullet Kit). After every passage,
the cells were kept for 5 days before the next passage was
performed. After reaching confluence, the medium was
changed to N2- or B27-supplemented DMEM F12 (Invit-
rogen). A final concentration of 10 ng/ml of growth factor
was achieved with the optional addition of one of the fol-
lowing growth factors: bFGF, SHH or GDNF (Invitrogen).
The cells were then cultured under differentiation condi-
tions for 5–7 days, with medium replacement every 2
days.
Low density seeding
The differentiation protocol 2 and protocol 3 were per-
formed also after seeding of NHA cells passage 0 at the fol-
lowing densities: 7 000, 5 000, 2 500 and 1 000 cells/cm2.
After seeding, the cells were cultured in expansion
medium (Cambrex AGM Bullet Kit) for 5 days, then the
medium was changed to N2- or B27-supplemented
DMEM F12 with bFGF (Invitrogen) for 5–7 days; the
medium was replaced every 2 days.
Protocol testing commitment of NHA cells passage 0
Low density seeding used for subcloning purposes was
established at 5 000 cells/cm2.
NHA cells were plated on Matrigel thin-coated (manufac-
turer's protocol; BD Biosciences) chamber slides and cul-
tured in expansion medium (Cambrex AGM Bullet Kit)
until they reached 50% or 95% confluence. Then the cells
were grown for 5–7 days in N2- or B27-supplemented
DMEM F12 with bFGF (Invitrogen), with medium
replacement every 2 days.
Immunocytochemistry
Immunocytochemistry assays based on double or triple
immunofluorescent labeling were performed. For
immunofluorescent studies, the cells were grown on ster-
ile slides or for subcloning experiment in a 16-well immu-
nocytochemistry dishes (Nunc). The cells were fixed in
4% paraformaldehyde in PBS for 15 minutes, permeabi-
lized with 0.1% Triton X-100 for 10 min at room temper-
ature and blocked with 1% donkey serum in PBS for one
hour at room temperature. For double or triple immu-
nolabeling, the fixed cells were subsequently incubated
with appropriate anti-human primary antibodies (1 h,
room temperature) listed in Table 1. Double- or triple-
labeling was achieved by simultaneous incubation with a
suitable combination of species-specific fluorochrome-
conjugated secondary antibodies (1 h, room tempera-
ture). For double immunolabeling, the mix of donkey
anti-rabbit AlexaFluor®488, 1:250 and donkey anti-mouse
AlexaFluor®594, 1:250 antibodies (Molecular Probes)
were applied; for triple-labelling the following combina-
tion of antibodies was used: donkey anti-rabbit Alex-
aFluor®488, 1:250, donkey anti-mouse AlexaFluor®594,
1:250, donkey anti-goat AlexaFluor®350, 1:250; (Molecu-
lar Probes). Controls with secondary antibodies alone,
and with matched isotype controls in place of primary
antibodies were processed in the same manner. After a
final rinse with PBS, the slides were mounted using Pro-
Long® Gold Antifade Reagent (Molecular Probes). ForPage 3 of 12
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DAPI (Molecular Probes) was used. The slides were cover-
slipped and examined using an Olympus BX-41 fluores-
cence microscope.
Cell Counting
Immunoassayed cells were analyzed with an Olympus BX-
41 fluorescence microscope. Ten fields were counted for
each cover-slip – with each field containing minimum 50
cells. The number of positive cells was averaged from at
least three cover-slips from three independent experi-
ments. The percentages of cells positive for MAP2, GFAP
and/or CD44 were calculated after differentiation.
Real time PCR
The RNA samples were obtained from undifferentiated
NHA cells and from non-neural population (differentia-
tion protocol 1), neural cells (differentiation protocol 2)
and population consists of both cell types (differentiation
protocol 3).
Total cellular RNA was isolated from cell cultures using
NucleoSpin RNA/Protein kit (MACHERY-NAGEL)
according to the manufacturer's protocol. Contaminating
residual genomic DNA was removed by DNase I digestion
and an aliquot containing 1 μg of isolated RNA was
reverse transcribed into single-stranded cDNA in a final
volume of 40 μl using QuantiTect Reverse Transcription
Kit (Qiagen).
A Real time quantitative PCR was performed on a Rotor
Gene 6000 (Corbett, Life Sciences, Australia) instrument
utilizing the SYBR® Green Master Mix (Applied Biosys-
tems, CA). Following MAP2 primers were used for ampli-
fication:
F 5' GCACTTCAAGGGAAGCTGAT 3', R 5' ATCAAAT-
GGTCCACTAGGCG 3'.
Each sample was amplified in triplicate (for each run) in
a reaction volume of 10 μl containing 50 ng cDNA, 1×
SYBR Green Master Mix and forward and reverse primer
35 ng each. The cycling conditions were as follows: 3 min
at 95°C (polymerase activation) followed by 40 cycles of
15 s at 95°C (denaturation), 45 s at 59°C (annealing) and
1 min at 72°C (extension). ACTB was used as a reference
gene for normalization of target genes expression levels.
Normalized relative expression level for a given gene of
non-neural cells, cell population consisted of neural and
non-neural cells and neural population obtained after dif-
ferentiation versus undifferentiated cells was calculated
utilizing the method described previously by Pfaffl et al.
and implemented into computer application REST2005
[21], based on each sample's average CT value and each
gene's average PCR efficiency. Additionally, the Real time
PCR products obtained after 20 cycles were analyzed on
2% agarose gel electrophoresis.
Western blot analysis
The protein samples were isolated from undifferentiated
NHA cells and from non-neural population (differentia-
tion protocol 1), neural cells (differentiation protocol 2)
and population consists of both cell types (differentiation
protocol 3).
The protein extracts from cell cultures were obtained with
the use of NucleoSpin RNA/Protein kit (MACHERY-
NAGEL). The commercially available Brain Tissue Lysate
was purchased from Abcam and used as positive control
in Western blot analysis. Equal amounts of protein
extracts, 25 μg per line, were separated by 5% SDS-PAGE
followed by transfer onto Immobilon™-P polyvinylidene
difluoride membranes (Sigma-Aldrich). After blocking
nonspecific binding the membranes were incubated for 1
hour at room temperature with rabbit anti-MAP2 primary
antibody (Santa Cruz Biotechnology, Inc.; sc-20172).
After extensive washing in TBST buffer (TRIS Buffered
Table 1: Primary antibodies applied for immunocytochemistry purposes
I Ab Host Manufacturer Dilution
anti-GFAP mouse Chemicon; MAB360 (1:400)
goat Santa Cruz Biotechnology, Inc.; sc-6171 (1:50)
anti-CD44 mouse Santa Cruz Biotechnology, Inc.; sc-7297 (1:100)
anti-MAP2 rabbit Santa Cruz Biotechnology, Inc.; sc-20172 (1:100)
anti-FIBRONECTIN rabbit Sigma; F 3648 (1:200)
anti-VIMENTIN goat Chemicon; AB-1620 (1:40)
anti-SOX2 rabbit Chemicon; AB5603 (1:1000)
Anti-TH mouse Santa Cruz Biotechnology, Inc.; sc- 25269 (1:100)
rabbit Pel-Freez Biologicals; P40101-0 (1:500)
anti-GABA rabbit Chemicon; AB141 (1:50)
anti-β-III-TUBULIN mouse Chemicon; MAB1637 (1:100)
anti-NESTIN mouse Santa Cruz Biotechnology, Inc.; sc-23927 (1:100)
anti-S100β mouse Santa Cruz Biotechnology, Inc.; sc-81709 (1:100)Page 4 of 12
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bated for 1 hour at room temperature with anti-rabbit sec-
ondary antibody (Santa Cruz Biotechnology, Inc.),
diluted 1:2000. Membrane was then washed in TBST
buffer and finally in TBS buffer (TRIS Buffered Saline; pH
7.5); antigen-antibody complexes were detected by
enhanced chemiluminescence, using Chemiluminescence
Luminol Reagent (Santa Cruz Biotechnology, Inc.) and
visualized with the use of BIO-RAD camera and Quantity
One software.
Statistical analysis
The effect of cell density on non-neural population per-
centage was assessed by the non-linear estimation by fit-
ting the experimental data to exponential curve. Log-
linear analysis was employed in order to analyse effects of
medium and growth factors used in cell culture to increase
percentage of neuronal cells. The differences in gene
expression levels were determined by the bootstrap rand-
omization technique, implemented in program
REST2005. Statistical significance was assumed for P-
value ≤ 0.05.
Results
NHA cells at the passage 0 showed one homogenous 
phenotype
We have already shown that – prior to differentiation,
proliferative NHA cells express GFAP, β-III-TUBULIN,
VIMENTIN, NESTIN, CD44 and MAP2 [1,2]. In this
report, we have also shown a co-expression of CD44,
GFAP and MAP2 by means of triple staining and SOX2
expression by a single staining (Figure 1). MAP2 expres-
sion in original population of NHA cells was confirmed
by Western blot and Real time PCR (Figure 2). MAP2
expression was low in NHA undifferentiated cells. Statisti-
cal analysis revealed that expression of MAP2 gene at
mRNA level is downregulated in non-neural cells and
upregulated in neural cells and mix of both populations
derived according to particular differentiation protocols
as compared to initial NHA cells, (P ≤ 0.05); (Figure 2).
Environmental factors affect the fate of NHA cells
Two completely different derivatives could be obtained
following exposure of NHA cells to two diverse environ-
ments.
Confluent NHA cells passage 0 exposed to N2- or B27-
supplemented DMEM F12, differentiated with almost
100% efficiency to neural cells (glial and neuronal) (Fig-
ures 3 and 4; Protocol 2). Undifferentiated cells present-
ing phenotype GFAP+, MAP2+, and CD44- were observed
only occasionally after following protocol number 2
(Table 2).
NHA cells that were seeded at a density of 10 000–15 000/
cm2, and exposed for one passage to expansion medium
(Cambrex medium with 3% FBS, rhEGF, insulin, and
ascorbic acid), until they reached confluence, and subse-
quently exposed to N2- or B27-supplemented DMEM
F12, produced three main populations of cells: (1) glial
[GFAP+, CD44+, MAP2-], (2) neuronal [MAP2+, CD44-,
GFAP-], and (3) non-neural cells robustly producing
FIBRONECTIN [CD44+, VIMENTIN+, GFAP-, MAP2-,
S100β-, SOX2-] in brief [CD44+, GFAP-, MAP2-]. Only 5–
10% of the cells presented phenotype [CD44+, GFAP-,
MAP2-] after differentiation at the passage 1 (Figures 3
Expression of neuronal, glial and progenitor markers in undifferentiated NHA cellsFigure 1
Expression of neuronal, glial and progenitor markers in undifferentiated NHA cells. Immunocytochemistry results 
show high expression of CD44, GFAP and low expression of MAP2 in NHA cells passage 0 (a, b, c, d) and demonstrate pres-
ence of NESTIN (e, f) and SOX2 (g, h) in initial uncommitted NHA as neural progenitors.Page 5 of 12
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approximately 40% of cells with [CD44+, GFAP-, MAP2-]
phenotype and equal proportions of neuronal and glial
cells (Figures 3 and 4; Protocol 3). Cells with phenotype
[GFAP+, MAP2+ CD44-] were – as before (Table 2), rarely
observed after following protocol 3.
On the other hand, NHA cells passage 0 exposed to the
expansion medium for 4–5 passages differentiated – with
100% efficiency, into cells expressing CD44, VIMENTIN,
and robustly producing extracellular matrix protein –
FIBRONECTIN (Figure 5; Protocol 1). The similar effect
was also obtained when NHA cells passage 0 were seeded
at a density of 1 000 cells/cm2 (Table 3). These cells
expressed no MAP2, GFAP, SOX2 and S100β (Figure 5) as
well as NESTIN and β-III-TUBULIN (data not shown) and
lost ability to provide neuronal [MAP2+, GFAP-] and glial
[GFAP+, MAP2-] cells after exposure to the neural differ-
entiation medium (DMEM F12 N2 with or without
growth factors). To this end, we temporarily recognized
these cells as non-neural.
Changes in density seeding of NHA cells at the passage 0
also influenced the fate of GFAP-positive progenitors pre-
sented here (see below).
Decreasing seeding density of NHA cells at the passage 0 
caused appearance of non-neural cells
NHA cells at the passage 0 were seeded at densities of 15
000 cells/cm2, 10 000 cells/cm2, 7 000 cells/cm2, 5 000
cells/cm2, 2 500 cells/cm2 and 1 000 cells/cm2. In spite of
the fact that they were all at the passage 0, the cells that
were seeded at densities lower than 7 000 cells/cm2 were
observed to present [CD44+, GFAP-, MAP2-, SOX2-] phe-
notype, once confluence was reached in the Cambrex
medium with 3% FBS, rhEGF and ascorbic acid, followed
by seven days exposure to DMEMF12 with N2 (B27).
Influence of seeding density on NHA cells passage 0 dif-
ferentiation is presented in Table 3.
In order to evaluate the effect of cell density on percentage
of non-neural population, experimental data were fitted
to exponential curve y = 122.81 * exp(-0.0004x) (p <
0.0001). Regression analysis explained 90% of variability
in percentage of non-neural population (r = -0.09509;
R^2 = 0.9043). These results point to the significant influ-
ence of the environmental factor (seeding density) on
NHA cells differentiation.
Subcloning of NHA cells do not suggest commitment 
before serum starvation
After low density seeding – 5 000 cells/cm2 (Figure 6a),
NHA cells passage 0 proliferated in expansion medium
and reached confluence. As was described above, conflu-
ent NHA cells were subsequently differentiated to neuro-
nal and glial cells when exposed to N2- (or B27-)
supplemented DMEM F12. Fifty percent of neuronal
[MAP2+, GFAP-] and forty-six percent of glial cells
[GFAP+, MAP2-] were obtained. In case when NHA cells
reached confluence before serum starvation, equal distri-
butions of two kinds of cells – rather than "colonies" of
neuronal and glial cells, were observed in the early stages
Expression pattern of MAP2 gene during NHA differentiationFigure 2
Expression pattern of MAP2 gene during NHA differ-
entiation. Results of Real time PCR and Western blot analy-
sis confirmed presence of MAP2 gene product in 
undifferentiated NHA cells both at mRNA and protein level 
and revealed changes in MAP2 expression in neural and non-
neural population after differentiation. (a) Results of Real 
time PCR for MAP2 relative expression presented as mean of 
relative expression and respective standard error. (b) Prod-
ucts of Real time PCR for MAP2 cDNA visualized on agarose 
gel electrophoresis. (c) Detection of levels of MAP2 protein 
expression by Western blot analysis. RNA and protein was 
isolated from particular cell populations (1, non-neural cells; 
2, undifferentiated cells; 3, population consists of neural and 
non-neural cells; 4, neural cells). MW, molecular weight 
marker.Page 6 of 12
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Table 2: The proportion of neuronal and glial cells obtained in different culture conditions
Differentiation condition
NHA-passage 0; 5–7 days
DMEM F12 with N2 DMEM F12 with B27
- bFGF SHH GDNF - bFGF SHH GDNF
Neuronal cells
MAP2+ GFAP- CD44-
50% 56% 54% 57% 50% 54% 55% 55%
Glial cells
GFAP+, CD44+, MAP2-
46% 41% 44% 42% 47% 44% 44% 43%
Undifferentiated cells
MAP2+, GFAP+, CD44-
4% 3% 2% 2% 3% 2% 3% 2%
Neural and non-neural differentiation of NHA cells resulted in changes in MAP2 and GFAP expressionFig re 3
Neural and non-neural differentiation of NHA cells resulted in changes in MAP2 and GFAP expression. Immu-
nocytochemistry data based on double staining show: silencing of neural markers [MAP2, GFAP] in non-neural cells obtained 
according to protocol 1 (a, b, c); presence of equal proportion of neuronal [MAP2+, GFAP-] and glial [GFAP+, MAP2-] cells 
after differentiation of NHA cells according to protocol 2 (d, e, f) and presence of the third non-neural population of MAP2 and 
GFAP negative cells accompanying neuronal [MAP2+, GFAP-] and glial [GFAP+, MAP2-] population as a result of protocol 3 (g, 
h, i).
BMC Biotechnology 2008, 8:56 http://www.biomedcentral.com/1472-6750/8/56of differentiation (i.e., 2–3 days of exposure to DMEM
F12 with N2 or B27), as well as after 5–7 days of differen-
tiation (Figure 6b).
When colonies of neuronal and glial cells were observed,
however, radical change in the differentiation protocol
was required to obtain them. Medium with serum had to
be replaced with DMEM F12 with N2 (B27) before reach-
ing confluence by the original NHA cell culture (passage
0, seeding density 5 000 cells/cm2). Presence of colonies
after that modification was a consequence of the fact that
committed in DMEM F12 with N2 (B27) at low density
stage glial and neuronal cells were proliferating within
free of cells spaces forming colonies (Figure 6c). It proved
that committed, proliferating cells forming colonies could
be detected by means of presented here subcloning
method.
GDNF, SHH and bFGF did not radically change the ratio 
between neuronal and glial cells
NHA cultured in DMEM F12 with N2 or B27 generated
neuronal and glial cells. After 5–7 days of differentiation,
we observed cell populations of 50% neuronal and 46%
glial and approximately 4% of undifferentiated cells
[GFAP+, MAP2+, CD44-] (Table 2). However, with the
addition of either bFGF, GDNF, or SHH, the populations
turned out to be 54–57% neuronal and 41–44% glial
(Table 2).
Statistical analysis indicated that influence of growth fac-
tors and supplements used in cell culture to increase per-
centage of neuronal cells was not significant; (P = 1.00).
Three derivatives of NHA cells present distinct expression of MAP2, GFAP and CD44Figure 4
Three derivatives of NHA cells present distinct expression of MAP2, GFAP and CD44. Results of triple immunos-
tainings applied to derivatives of NHA cells obtained according particular differentiation protocols reveal: formation of one 
phenotypically homogenous [CD44+, MAP2-, GFAP-] non-neural population as a result of protocol 1 (a, b, c, d); presence of 
neuronal [MAP2+, CD44-, GFAP-] and glial [GFAP+, CD44+, MAP2-] populations in case of protocol 2 (e, f, g, h) and appear-
ance of the third population of non-neural cells [CD44+, MAP2-, GFAP-] coexisting with neuronal [MAP2+, CD44-, GFAP-] 
and glial [GFAP+, CD44+, MAP2-] lineage in case of protocol 3 (i, j, k, l).
Table 3: Influence of seeding density on percentage of non-neural 
cells obtained after differentiation
Seeding density Non-neural cells percentage
15 000 cells/cm2 0%
10 000 cells/cm2 0%
7 000 cells/cm2 10%
5 000 cells/cm2 20%
2 500 cells/cm2 60%
1 000 cells/cm2 100%Page 8 of 12
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Neuronal MAP2 positive cells obtained after NHA cells
differentiation were able to produce GABA (gamma-ami-
nobutyric acid) and express TH (tyrosine hydroxylase).
GABA-ergic positive cells dominated (Figure 7).
Discussion
The main goal of our current research was to obtain the
highest possible percentage of biotechnologically useful-
cetacholaminergic and GABA-ergic, neuronal cells via dif-
ferentiation of NHA neural progenitors. To this end, we
considered the influence of intrinsic and extrinsic factors
during NHA cells differentiation. NHA cells have been
described as GFAP-positive neural progenitors in our pre-
vious reports [1,2], but here, for the first time, we showed
that these cells express SOX2 at the passage 0. In spite of
the fact, that expression of SOX genes are associated with
neural stem cells and SOX proteins are regarded as mark-
ers of neural primordium [22], NHA differentiation status
is not obvious. According to our results these cells were
identified as neural progenitors, but we couldn't exclude a
possibility that NHA may reveal features of stem cells
[1,2]. Anyway, the influence of intrinsic and extrinsic
events should be considered not only in the context of
stem cells, since also progenitors are biotechnologically
valuable.
Characterization of non-neural derivatives of NHA cells cul-tured in expansion mediumFigure 5
Characterization of non-neural derivatives of NHA 
cells cultured in expansion medium. Immunocytochem-
istry results demonstrate silencing of neural markers [GFAP, 
S100β, MAP2] expression, presence of VIMENTIN, CD44 
and abundant expression of FIBRONECTIN (a, b, d) as well 
as lack of SOX2 (c) in NHA cell derivatives obtained after 
four passages in Cambrex expansion medium with FBS (dif-
ferentiation protocol 1).
Subcloning method revealed undifferentiated NHA cells as non-committed homogenous cell populationFigure 6
Subcloning method revealed undifferentiated NHA cells as non-committed homogenous cell population. Immu-
nocytochemistry results show: co-expression of GFAP and MAP2 in undifferentiated NHA cells passage 0 seeded at a very low 
density (5 000 cells/cm2) (a); equal "non-colonial" distribution of cells representing phenotype [MAP2+, CD44-] and phenotype 
[CD44+, MAP2-] obtained as a result of neural differentiation of NHA cells which previously reached confluence in medium 
with serum (b); ability of NHA cells to form colonies obtained as a result of neural differentiation of non-confluent cells (c).
Differentiation of neuronal lineage of NHA cells resulted in presence of GABA-ergic nd catecholaminergic cellsFigu  7
Differentiation of neuronal lineage of NHA cells 
resulted in presence of GABA-ergic and catecho-
laminergic cells. Immunocytochemistry data show pres-
ence of GABA-positive and TH-positive cells as derivatives of 
neural differentiation of NHA cells according to protocol 2 
(a, b) and demonstrate that TH positive cells present β-III-
TUBULIN expression (b).Page 9 of 12
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passage 0 consists of two or more cell populations pre-
senting permanent, diverse intrinsic regulators of differen-
tiation. In other words, we found no data to support the
idea that the fate of NHA cells is determined at the passage
0 before serum starvation (Figures 1 and 6) [1,2]. How-
ever, we cannot exclude the possibility that NHA cells
were changing their phenotype periodically and discretely
in accordance with the continuum model [18]. A hypoth-
esis of the permanent fate pre-determination was also
undermined by the results showing that uncommitted
NHA cells were very selectively differentiated in serum-
free conditions into neural cells. On the other hand, in
medium containing serum, NHA cells were directed, after
4–5 passages or extremely low density seeding at the pas-
sage 0, with 100% efficiency towards cells recognized tem-
porarily as non-neural on the basis of presented
phenotype [CD44+, VIMENTIN+, FIBRONECTIN+,
SOX2-, MAP2-, GFAP-, S100β-, NESTIN-, β-III-TUBULIN-
] and disability to differentiate into the neuronal deriva-
tives (Figure 5; for NESTIN and β-III-TUBULIN data not
shown). Provided evidences entitled to regard this popu-
lation as non-neural, nevertheless, defining exact pheno-
type of these cells requires additional investigation.
Our results showed that environmental changes triggered
two different types of differentiation: neural and non-neu-
ral (Figures 3, 4 and 5). These data fit the instructive
model of differentiation. It also showed, that time of
exposure to a particular environment is important during
the differentiation of NHA progenitors. The role of the
duration of exposure to a particular environment in regu-
lating differentiation has been recognized as a kinetic fac-
tor [23].
In spite of findings on the determination of neural versus
non-neural fate by means of simple environmental
manipulation, we were unable to obtain strictly neuronal
or strictly glial cells from any of the cell culture conditions
tested. This shows the inadequacy of the instructive model
in explaining how glial vs. neuronal fate determination is
regulated during GFAP positive neural progenitors (NHA)
differentiation. We should ask "why" initially uncommit-
ted NHA cells always end up differentiating into two types
of neural cells – i.e., neuronal and glial, even when
exposed to different – serum free environments. Stochas-
tic and continuum models of differentiation do offer the
answer to this question. In accordance with the stochastic
model, stochastic events can trigger intracellular develop-
mental diversity and cause the appearance of two (or
more) different responses to one environment [11]. Refer-
ring to the Enver suggestion that "hematopoietic stem
cells play dice" [12], we may suggest that after serum star-
vation "NHA neural progenitors toss a coin and – getting
a head, choose a neuronal fate; whereas getting tail meant
choosing a glial fate." The continuum model – with its
fluctuating reversible changes during cell cycle temporar-
ily biasing the fate of progenitors, also fits the results that
we observed. The stochastic or continuum nature of the
process regulating neuronal vs. glial cells determination
was supported by the results of our sub-cloning experi-
ment (Figure 6). In essence, these models can explain our
data, which shows that growth factors such as bFGF,
GDNF, or SHH were not able to increase dramatically the
percentage of neuronal cells within, five to seven days
exposure to the serum free medium (Table 2). Both mod-
els are based on the thesis that intracellular events cause
certain cellular independence in terms of their responses
to environmental changes. In our experiments, growth
factors were unable to trigger only neuronal differentia-
tion from neural progenitors (NHA), which is in accord-
ance with stochastic and continuum models.
It seems important, from the biotechnological point of
view, that we were able to limit the percentage of non-
neural cells [CD44+, VIMENTIN+, FIBRONECTIN+,
GFAP-, MAP2-, S100β-, SOX2-] (Figures 3 and 4) since
cells robustly producing FIBRONECTIN could be hazard-
ous as an element of graft in the central nervous system
[24,25]. Moreover these cells were unable to provide neu-
ronal cells and therefore we recognized them as useless
considering our project target – the procurement of neu-
ronal cells. In spite of the successful elimination of non-
neural cells, we did not manage to increase significantly
the ratio between neuronal versus glial cells (Table 2). It
could be disappointing that we were almost unable to
break the symmetrical proportion between neuronal and
glial cells while testing several growth factors. Neverthe-
less, we can still propose an answer for the question of
why either stochastic or continuum models, basing on the
primary role of intrinsic factors and the permissive role of
extrinsic factors, can describe the biologically designed
process of neural progenitors (NHA) differentiation. It is
very likely that in vitro glial cells – as in in vivo ones, sup-
port neuronal cell growth, differentiation, and maturation
[26,27]. Since the biological process regulating the differ-
entiation of neural progenitors seems to be rational in its
simultaneous provision of glial and neuronal cells, bio-
technological manipulations leading to the obtainment
of only – or almost only, neuronal cells could result in the
elimination of natural supporters of neuronal cells.
Conclusion
We made two key observations from our experiments. The
first is that environmentally regulated bifurcation towards
neural vs. non-neural cells occurred in accordance with
the deterministic model. The second is that environmen-
tally unbreakable, symmetrical, and simultaneous differ-
entiation towards glial and neuronal cells occurred in
accordance with the stochastic and continuum modelsPage 10 of 12
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stochastic or the continuum model is better in describing
neural differentiation of NHA progenitors. Nevertheless,
approving either one of those two models means accept-
ing the limitations of commonly used cell cultures manip-
ulations to increase percentage yield of neuronal cells.
Our approach allowed for the elimination of non-neural
cells, and the maximal procurement of about 60% neuro-
nal cells. In the application of more manipulative biotech-
nological procedures, biological reasons for the
limitations of typical methods should be carefully and
meticulously scrutinised, since it is possible that physio-
logical cooperation between neuronal and glial cells lays
hidden behind these limitations. Still, we were able to
show that taking into account more than one model of
differentiation can be helpful during biotechnological
preparation of cells useful for transplantology purposes.
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